Aegis Writes a New Chapter on Pathogen Surveillance
Accesswire
*A US lab broadens its surveillance efforts to be able to respond to emerging pathogens and envision a future of improved public..
SARS-CoV-2 Delta variant
News and Video Search Results
News coverage
-
COVID-19 Virus Is Evolving Rapidly In White-Tailed Deer
Eurasia Review
-
The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricides
Accesswire
-
Invivyd Announces Positive Initial Data from Ongoing Phase 1 Clinical Trial of VYD222, a Monoclonal Antibody Candidate in Development for the Prevention of Symptomatic COVID-19 in Immunocompromised People
GlobeNewswire
-
Bavarian Nordic Reports 12-Month Durability Data from a Phase 2 Clinical Trial of its COVID-19 Vaccine Candidate
GlobeNewswire
- More about:
Ohio
0 shares
1 views
You might like
SARS-CoV-2 Delta variant media coverage
China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use
PR Newswire Asia
CHENGDU, China, June 9, 2023 /PRNewswire/ -- On June 8^th, 2023, Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Trivalent..
-
Invivyd Publishes Model for Evaluating Biomarker Correlates of Protection for Monoclonal Antibodies Against Symptomatic COVID-19
GlobeNewswire
-
INVIVYD, INC. (NASDAQ: IVVD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD)
GlobeNewswire
Advertisement
More coverage
-
Invivyd, Inc. (IVVD) Class Action Notice: Contact Robbins LLP for Information About Filing a Lead Plaintiff Motion in Class Action Against Invivyd, Inc.
GlobeNewswire
-
Invivyd, Inc. (IVVD) Class Action Alert: Robbins LLP Urges Shareholders to Contact the Firm Regarding Representation in the Class Action Against Invivyd, Inc.
GlobeNewswire
-
Invivyd, Inc. (IVVD) f/k/a Adagio Therapeutics, Inc. Shareholder Notice: Robbins LLP Informs Investors of Class Action Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc.
GlobeNewswire
-
INVIVYD, INC. (NASDAQ: IVVD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Invivyd, Inc. f/k/a Adagio Therapeutics, Inc. (NASDAQ: IVVD)
GlobeNewswire